{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:35:25Z","timestamp":1791819325944,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00120-024-02285-8","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T23:01:46Z","timestamp":1709161306000},"page":"241-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Palliative Chirurgie des metastasierten Prostatakarzinoms","Palliative surgery for metastatic prostate cancer"],"prefix":"10.1007","volume":"63","author":[{"given":"Axel","family":"Heidenreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"issue":"2 Pt 1","key":"2285_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0022-5347(01)67075-7","volume":"154","author":"G Aus","year":"1995","unstructured":"Aus\u00a0G, Hugosson\u00a0J, Norl\u00e9n\u00a0L (1995) Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J\u00a0Urol 154(2 Pt 1):466\u2013469","journal-title":"J Urol"},{"issue":"3","key":"2285_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/SPC.0000000000000078","volume":"8","author":"C Piper","year":"2014","unstructured":"Piper\u00a0C, Porres\u00a0D, Pfister\u00a0D, Heidenreich\u00a0A (2014) The role of palliative surgery in castration-resistant prostate cancer. Curr Opin Support Palliat Care 8(3):250\u2013257","journal-title":"Curr Opin Support Palliat Care"},{"key":"2285_CR3","first-page":"e9","volume":"33: 202","author":"A Patrikidou","year":"2015","unstructured":"Patrikidou\u00a0A, Brureau\u00a0L, Casenave\u00a0J et\u00a0al (2015) Locoregional symptoms in patients with de novo metastatic prostate cancer: morbidity, management, and disease outcome. Urol Oncol 33: 202:e9\u201317","journal-title":"Urol Oncol"},{"issue":"2","key":"2285_CR4","doi-asserted-by":"publisher","first-page":"e034331","DOI":"10.1136\/bmjopen-2019-034331","volume":"10","author":"YG Tan","year":"2020","unstructured":"Tan\u00a0YG, Pang\u00a0L, Khalid\u00a0F, Poon\u00a0R, Huang\u00a0HH, Chen\u00a0K, Tay\u00a0KJ, Lau\u00a0W, Cheng\u00a0C, Ho\u00a0H, Yuen\u00a0J (2020) Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a\u00a0large prospective Uro-oncology registry. BMJ Open 10(2):e34331","journal-title":"BMJ Open"},{"key":"2285_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1464-410X.2010.09356.x","volume":"106","author":"TL Krupski","year":"2010","unstructured":"Krupski\u00a0TL, Stukenborg\u00a0GJ, Moon\u00a0K, Theodorescu\u00a0D (2010) The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer. BJU Int 106:1477\u20131483","journal-title":"BJU Int"},{"key":"2285_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.5114\/aoms.2010.17095","volume":"6","author":"DP Michielsen","year":"2010","unstructured":"Michielsen\u00a0DP, Coomans\u00a0D, Engels\u00a0B, Braeckman\u00a0JG (2010) Bipolar versus monopolar technique for palliative transurethral prostate resection. Arch Med Sci 6:780\u2013786","journal-title":"Arch Med Sci"},{"key":"2285_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1464-410X.2006.06529.x","volume":"99","author":"M Marszalek","year":"2007","unstructured":"Marszalek\u00a0M, Ponholzer\u00a0A, Rauchenwald\u00a0M, Madersbacher\u00a0S (2007) Palliative transurethral resection of the prostate: functional outcome and impact on survival. BJU Int 99:56\u201359","journal-title":"BJU Int"},{"issue":"8","key":"2285_CR8","doi-asserted-by":"publisher","first-page":"363.e7","DOI":"10.1016\/j.urolonc.2018.05.004","volume":"36","author":"J Pelletier","year":"2018","unstructured":"Pelletier\u00a0J, Cyr\u00a0SJ, Julien\u00a0AS, Fradet\u00a0Y, Lacombe\u00a0L, Toren\u00a0P (2018) Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer. Urol Oncol 36(8):363.e7\u2013363.e11","journal-title":"Urol Oncol"},{"issue":"6","key":"2285_CR9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s10103-019-02913-2","volume":"35","author":"M Tang","year":"2020","unstructured":"Tang\u00a0M, Wang\u00a0C, Li\u00a0P, Zhang\u00a0Q, Qian\u00a0J, Meng\u00a0X (2020) Efficacy and outcome of holmium laser enucleation of prostate in patients with urinary retention due to advanced prostate cancer. Lasers Med Sci 35(6):1307\u20131313","journal-title":"Lasers Med Sci"},{"issue":"3","key":"2285_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/end.2013.0432","volume":"28","author":"A Becker","year":"2014","unstructured":"Becker\u00a0A, Placke\u00a0A, Kluth\u00a0L, Schwarz\u00a0R, Isbarn\u00a0H, Chun\u00a0F, Heuer\u00a0R, Schlomm\u00a0T, Seiler\u00a0D, Engel\u00a0O, Fisch\u00a0M, Graefen\u00a0M, Ahyai\u00a0SA (2014) Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms\u2014a retrospective feasibility study. J\u00a0Endourol 28(3):335\u2013341","journal-title":"J Endourol"},{"key":"2285_CR11","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","volume":"392","author":"CC Parker","year":"2018","unstructured":"Parker\u00a0CC, James\u00a0ND, Brawley\u00a0CD, Clarke\u00a0NW, Hoyle\u00a0AP, Ali\u00a0A, Ritchie\u00a0AWS, Attard\u00a0G, Chowdhury\u00a0S, Cross\u00a0W et\u00a0al (2018) Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): A randomized controlled phase\u00a03\u00a0trial. Lancet 392:2353\u20132366","journal-title":"Lancet"},{"key":"2285_CR12","doi-asserted-by":"publisher","first-page":"E250","DOI":"10.1111\/bju.12169","volume":"112","author":"AC Won","year":"2013","unstructured":"Won\u00a0AC, Gurney\u00a0H, Marx\u00a0G, De Souza\u00a0P, Patel\u00a0MI (2013) Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer. BJU Int 112:E250\u2013E255","journal-title":"BJU Int"},{"issue":"5","key":"2285_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.euf.2016.08.009","volume":"2","author":"A Heidenreich","year":"2016","unstructured":"Heidenreich\u00a0A (2016) Palliative radical (cysto-)prostatectomy for locally advanced, symptomatic castration-resistant prostate cancer. Eur Urol Focus 2(5):478\u2013479","journal-title":"Eur Urol Focus"},{"issue":"11","key":"2285_CR14","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s00120-011-2716-2","volume":"50","author":"D Pfister","year":"2011","unstructured":"Pfister\u00a0D, Epplen\u00a0R, Porres-Knoblauch\u00a0D, Heidenreich\u00a0A (2011) Possibilities for surgical correction of an anastomotic stricture after radical prostatectomy. Urologe\u00a0A 50(11):1392\u20131395","journal-title":"Urologe A"},{"issue":"2","key":"2285_CR15","first-page":"162","volume":"16","author":"N Simforoosh","year":"2019","unstructured":"Simforoosh\u00a0N, Dadpour\u00a0M, Mofid\u00a0B (2019) Cytoreductive and palliative radical prostatectomy, extended lymphadenectomy and bilateral orchiectomy in advanced prostate cancer with oligo and widespread bone metastases: result of a\u00a0feasibility, our initial experience. Urol\u00a0J 16(2):162\u2013167","journal-title":"Urol J"},{"issue":"2","key":"2285_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.eururo.2018.03.031","volume":"74","author":"CA Reichard","year":"2018","unstructured":"Reichard\u00a0CA, Gregg\u00a0JR, Achim\u00a0MF, Aparicio\u00a0AM, Pettaway\u00a0CA, Pisters\u00a0LL, Ward\u00a0JF, Davis\u00a0JW, Chapin\u00a0BF (2018) Radical prostatectomy in metastatic castration-resistant prostate cancer: feasibility, safety, and quality of life outcomes. Eur Urol 74(2):140\u2013143","journal-title":"Eur Urol"},{"issue":"3","key":"2285_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/bju.15088","volume":"126","author":"A Heidenreich","year":"2020","unstructured":"Heidenreich\u00a0A, Bludau\u00a0M, Bruns\u00a0C, Nestler\u00a0T, Porres\u00a0D, Pfister\u00a0DJKP (2020) Pelvic exenteration surgery in patients with locally advanced castration-na\u00efve and castration-resistant, symptomatic prostate cancer. BJU Int 126(3):342\u2013349","journal-title":"BJU Int"},{"key":"2285_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1159\/000369545","volume":"37","author":"P Rocha","year":"2014","unstructured":"Rocha\u00a0P, Morgan\u00a0CJ, Templeton\u00a0AJ et\u00a0al (2014) Prognostic impact of C\u2011reactive protein in metastatic prostate cancer: a\u00a0systematic review and meta-analysis. Oncol Res Treat 37:772\u2013776","journal-title":"Oncol Res Treat"},{"key":"2285_CR19","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/ijc.31256","volume":"142","author":"R Arthur","year":"2018","unstructured":"Arthur\u00a0R, Williams\u00a0R, Garmo\u00a0H et\u00a0al (2018) Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int J Cancer 142:2254\u20132262","journal-title":"Int J Cancer"},{"key":"2285_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/bju.12452","volume":"113","author":"DP Nguyen","year":"2014","unstructured":"Nguyen\u00a0DP, Li\u00a0J, Tewari\u00a0AK (2014) Inflammation and prostate cancer: the role of interleukin\u00a06 (IL-6). BJU Int 113:986\u2013992","journal-title":"BJU Int"},{"issue":"3","key":"2285_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1464-410X.2005.05302.x","volume":"95","author":"M Lodde","year":"2005","unstructured":"Lodde\u00a0M, Pycha\u00a0A, Palermo\u00a0S, Comploj\u00a0E, Hohenfellner\u00a0R (2005) Uretero-ureterocutaneostomy (wrapped by omentum). BJU Int 95(3):371\u2013373","journal-title":"BJU Int"},{"key":"2285_CR22","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.ju.0000181826.65272.7b","volume":"174","author":"D Leibovici","year":"2005","unstructured":"Leibovici\u00a0D, Kamat\u00a0AM, Pettaway\u00a0CA et\u00a0al (2005) Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer. J\u00a0Urol 174:2186\u20132189","journal-title":"J Urol"},{"key":"2285_CR23","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1097\/01.ju.0000091656.94825.90","volume":"170","author":"AM Kamat","year":"2003","unstructured":"Kamat\u00a0AM, Huang\u00a0SF, Bermejo\u00a0CE et\u00a0al (2003) Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J\u00a0Urol 170:1868\u20131872","journal-title":"J Urol"},{"key":"2285_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0022-5347(17)40150-9","volume":"143","author":"RK Chiou","year":"1990","unstructured":"Chiou\u00a0RK, Chang\u00a0WY, Horan\u00a0JJ (1990) Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy. J\u00a0Urol 143:957\u2013959","journal-title":"J Urol"},{"issue":"2","key":"2285_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MOU.0000000000000849","volume":"31","author":"P Paffenholz","year":"2021","unstructured":"Paffenholz\u00a0P, Heidenreich\u00a0A (2021) Modern surgical strategies in the management of complex ureteral strictures. Curr Opin Urol 31(2):170\u2013176","journal-title":"Curr Opin Urol"},{"key":"2285_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11255-013-0458-3","volume":"45","author":"S Misra","year":"2013","unstructured":"Misra\u00a0S, Coker\u00a0C, Richenberg\u00a0J (2013) Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right? Int Urol Nephrol 45:627\u2013632","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"2285_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.21873\/invivo.13145","volume":"37","author":"T Hori","year":"2023","unstructured":"Hori\u00a0T, Makino\u00a0T, Kawahara\u00a0T, Urata\u00a0S, Miyagi\u00a0T (2023) Effectiveness of double\u2011J metallic mesh ureteral stents for malignant ureteral obstruction: a\u00a0retrospective study. In Vivo 37(2):806\u2013810","journal-title":"In Vivo"},{"issue":"6","key":"2285_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1089\/end.2017.0611","volume":"35","author":"JS Hsu","year":"2021","unstructured":"Hsu\u00a0JS, Huang\u00a0CY, Liu\u00a0KL, Chow\u00a0PM (2021) Risk factors for primary failure of metallic ureteral stents: experience from a\u00a0tertiary center. J\u00a0Endourol 35(6):912\u2013918","journal-title":"J Endourol"},{"issue":"5","key":"2285_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/21681805.2017.1331262","volume":"51","author":"S Bier","year":"2017","unstructured":"Bier\u00a0S, Amend\u00a0B, Wagner\u00a0E, Rausch\u00a0S, Mischinger\u00a0J, Neumann\u00a0E, St\u00fchler\u00a0V, Joerg\u00a0H, Todenhoefer\u00a0T, Stenzl\u00a0A, Bedke\u00a0J, Kruck\u00a0S (2017) The thermoexpandable nitinol stent: a\u00a0long-term alternative in patients without nephropathy or malignancy. Scand J Urol 51(5):388\u2013391","journal-title":"Scand J Urol"},{"issue":"3","key":"2285_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1464-410X.2008.08018.x","volume":"103","author":"S Agrawal","year":"2009","unstructured":"Agrawal\u00a0S, Brown\u00a0CT, Bellamy\u00a0EA, Kulkarni\u00a0R (2009) The thermo-expandable metallic ureteric stent: an 11-year follow-up. BJU Int 103(3):372\u2013376","journal-title":"BJU Int"},{"issue":"6","key":"2285_CR31","first-page":"903","volume":"48","author":"V Gauhar","year":"2022","unstructured":"Gauhar\u00a0V, Pirola\u00a0GM, Scarcella\u00a0S, De Angelis\u00a0MV, Giulioni\u00a0C, Rubilotta\u00a0E, Gubbiotti\u00a0M, Lim\u00a0EJ, Law\u00a0YXT, Wroclawski\u00a0ML, Tiong\u00a0HY, Castellani\u00a0D (2022) Nephrostomy tube versus double J ureteral stent in patients with malignant ureteric obstruction. A systematic review and meta-analysis of comparative studies. Int Braz J Urol 48(6):903\u2013914","journal-title":"Int Braz J Urol"},{"issue":"1","key":"2285_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/UA.UA_18_19","volume":"12","author":"S Kumar","year":"2020","unstructured":"Kumar\u00a0S, Dutt\u00a0UK, Singh\u00a0S, Dorairajan\u00a0LN, Sreerag\u00a0KS, Zaphu\u00a0T, Manikandan\u00a0R (2020) Prospective audit of complications after ultrasonography-guided percutaneous nephrostomy for upper urinary tract obstruction using modified Clavien classification system. Urol Ann 12(1):31\u201336","journal-title":"Urol Ann"},{"issue":"4","key":"2285_CR33","first-page":"404","volume":"71","author":"F New","year":"2018","unstructured":"New\u00a0F, Deverill\u00a0S, Somani\u00a0BK (2018) Role of percutaneous nephrostomy in end of life prostate cancer patients: a\u00a0systematic review of the literature. Cent european J Urol 71(4):404\u2013409","journal-title":"Cent european J Urol"},{"key":"2285_CR34","doi-asserted-by":"publisher","first-page":"175628722312077","DOI":"10.1177\/17562872231207729","volume":"15","author":"E Osinibi","year":"2023","unstructured":"Osinibi\u00a0E, Doan\u00a0H, Mercado-Campero\u00a0A, Abbaraju\u00a0J, Masood\u00a0S, Madaan\u00a0S (2023) The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective? Ther Adv Urol 15:17562872231207729","journal-title":"Ther Adv Urol"},{"issue":"2","key":"2285_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/21681805.2014.938694","volume":"49","author":"LH Bigum","year":"2015","unstructured":"Bigum\u00a0LH, Spielmann\u00a0ME, Juhl\u00a0G, Rasmussen\u00a0A (2015) A qualitative study exploring male cancer patients\u2019 experiences with percutaneous nephrostomy. Scand J Urol 49(2):162\u2013168","journal-title":"Scand J Urol"},{"issue":"4","key":"2285_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1464-410X.1992.tb15799.x","volume":"70","author":"DP Sandhu","year":"1992","unstructured":"Sandhu\u00a0DP, Mayor\u00a0PE, Sambrook\u00a0PA, George\u00a0NJ (1992) Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol 70(4):412\u2013416","journal-title":"Br J Urol"},{"key":"2285_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1464-410X.1981.tb03195.x","volume":"53","author":"B Kihl","year":"1981","unstructured":"Kihl\u00a0B, Bratt\u00a0CG (1981) Reimplantation of the ureter in prostatic carcinoma associated with bilateral ureteric obstruction. Br J Urol 53:349\u2013352","journal-title":"Br J Urol"},{"key":"2285_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.urology.2021.07.012","volume":"157","author":"BM Launer","year":"2021","unstructured":"Launer\u00a0BM, Redger\u00a0KD, Koslov\u00a0DS, Sax-Bolder\u00a0AN, Higuchi\u00a0TT, Windsperger\u00a0AP, Flynn\u00a0BJ (2021) Long-term follow up of ileal ureteral replacement for complex ureteral strictures: single institution study. Urology 157:257\u2013262","journal-title":"Urology"},{"key":"2285_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-2004-830087","volume":"35","author":"A Heidenreich","year":"2004","unstructured":"Heidenreich\u00a0A, Ohlmann\u00a0C, Braun\u00a0M (2004) Palliative subcutaneous urinary diversion in malignant ureteral obstruction (Detour system). Aktuelle Urol 35:429\u2013441","journal-title":"Aktuelle Urol"},{"key":"2285_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eururo.2006.11.008","volume":"52","author":"SN Lloyd","year":"2007","unstructured":"Lloyd\u00a0SN, Tirukonda\u00a0P, Biyani\u00a0CS et\u00a0al (2007) The detour extra-anatomic stent\u2014a permanent solution for benign and malignant ureteric obstruction? Eur Urol 52:193\u2013198","journal-title":"Eur Urol"},{"key":"2285_CR41","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1007\/s00120-012-3039-7","volume":"51","author":"A Janitzky","year":"2012","unstructured":"Janitzky\u00a0A, Borski\u00a0J, Porsch\u00a0M et\u00a0al (2012) Long-term results for subcutaneous Detour1prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications. Urologe\u00a0A 51:1714\u20131721","journal-title":"Urologe A"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-024-02285-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-024-02285-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-024-02285-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T16:02:26Z","timestamp":1709740946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-024-02285-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2285"],"URL":"https:\/\/doi.org\/10.1007\/s00120-024-02285-8","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"15 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Heidenreich, C.\u00a0Bach und D.\u00a0Pfister geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}